Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $17.3800 (-2.69%) ($17.3500 - $17.3800) on Wed. Dec. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 54 | Latest Price | $17.3800(-2.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(47%) ARKG(46%) ARKK(46%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.685% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-16%) TLT(-11%) USO(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $17.9 | 5 Day Moving Average | $17.77(-2.19%) | 10 Day Moving Average | $17.91(-2.96%) | 20 Day Moving Average | $17.9(-2.91%) | To recent high | -12.6% | To recent low | 18.3% | Market Cap | $1.291b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |